Human NIBAN2/bA356B19.6/C9orf88 ORF/cDNA clone-Lentivirus plasmid (NM_022833.4)

Cat. No.: pGMLV001974
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human NIBAN2/bA356B19.6/C9orf88 Lentiviral expression plasmid for NIBAN2 lentivirus packaging, NIBAN2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to FAM129B/NIBAN2/bA356B19.6 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1061.94
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLV001974
Gene Name NIBAN2
Accession Number NM_022833.4
Gene ID 64855
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2241 bp
Gene Alias bA356B19.6,C9orf88,FAM129B,MEG-3,MINERVA,OC58
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGGGGACGTGCTGTCCACGCACCTGGACGACGCCCGGCGCCAGCACATCGCAGAAAAAACCGGGAAGATCCTGACGGAGTTCCTCCAGTTCTATGAAGACCAGTATGGCGTGGCTCTCTTCAACAGCATGCGCCATGAGATTGAGGGCACGGGGCTGCCGCAGGCCCAGCTGCTCTGGCGCAAGGTGCCACTGGACGAGCGCATCGTCTTCTCGGGGAACCTCTTCCAGCACCAGGAGGACAGCAAGAAGTGGAGAAACCGCTTCAGCCTCGTGCCCCACAACTACGGGCTGGTGCTCTACGAAAACAAAGCGGCCTATGAGCGGCAGGTCCCACCACGAGCCGTCATCAACAGTGCAGGCTACAAAATCCTCACGTCCGTGGACCAATACCTGGAGCTCATTGGCAACTCCTTACCAGGGACCACGGCAAAGTCGGGCAGTGCCCCCATCCTCAAGTGCCCCACACAGTTCCCGCTCATCCTCTGGCATCCTTATGCGCGTCACTACTACTTCTGCATGATGACAGAAGCCGAGCAGGACAAGTGGCAGGCTGTGCTGCAGGACTGCATCCGGCACTGCAACAATGGAATCCCTGAGGACTCCAAGGTAGAGGGCCCTGCGTTCACAGATGCCATCCGCATGTACCGACAGTCCAAGGAGCTGTACGGCACCTGGGAGATGCTGTGTGGGAACGAGGTGCAGATCCTGAGCAACCTGGTGATGGAGGAGCTGGGCCCTGAGCTGAAGGCAGAGCTCGGCCCGCGGCTGAAGGGGAAACCGCAGGAGCGGCAGCGGCAGTGGATCCAGATCTCGGACGCCGTGTACCACATGGTGTACGAGCAGGCCAAGGCGCGCTTCGAGGAGGTGCTGTCCAAGGTGCAGCAGGTGCAGCCGGCCATGCAGGCCGTCATCCGAACTGACATGGACCAAATTATCACCTCCAAGGAGCACCTTGCCAGCAAGATCCGAGCCTTCATCCTCCCCAAGGCAGAGGTGTGCGTGCGGAACCATGTCCAGCCCTACATCCCATCCATCCTGGAGGCCCTGATGGTCCCCACCAGCCAGGGCTTCACTGAGGTGCGAGATGTCTTCTTCAAGGAGGTCACGGACATGAACCTGAACGTCATCAACGAGGGCGGCATTGACAAGCTGGGCGAGTACATGGAGAAGCTGTCCCGGCTGGCGTACCACCCCCTGAAGATGCAGAGCTGCTATGAGAAGATGGAGTCGCTGCGACTGGACGGGCTGCAGCAGCGATTTGATGTGTCCAGCACGTCCGTGTTCAAGCAGCGAGCCCAGATCCACATGCGGGAGCAAATGGACAATGCCGTGTATACGTTCGAGACCCTCCTGCACCAGGAGCTGGGGAAGGGGCCCACCAAGGAGGAGCTGTGCAAGTCCATCCAGCGGGTCCTGGAGCGGGTGCTGAAGAAATACGACTACGACAGCAGCTCTGTGCGGAAGAGGTTCTTCCGGGAGGCGCTGCTGCAGATCAGCATCCCGTTCCTGCTCAAGAAGCTGGCCCCTACCTGCAAGTCGGAGCTGCCCCGGTTCCAGGAGCTGATCTTCGAGGACTTTGCCAGGTTCATCCTGGTGGAAAACACGTACGAGGAGGTGGTGCTGCAGACCGTCATGAAGGACATCCTGCAGGCTGTGAAGGAGGCCGCGGTGCAGAGGAAGCACAACCTCTACCGGGACAGCATGGTCATGCACAACAGCGACCCCAACCTGCACCTGCTGGCCGAGGGCGCCCCCATCGACTGGGGCGAGGAGTACAGCAACAGCGGCGGGGGCGGCAGCCCCAGCCCCAGCACCCCGGAGTCAGCCACCCTCTCGGAAAAGCGACGGCGCGCCAAGCAGGTGGTCTCTGTGGTCCAGGATGAGGAGGTGGGGCTGCCCTTTGAGGCTAGCCCTGAGTCACCACCACCTGCGTCCCCGGACGGTGTCACTGAGATCCGAGGCCTGCTGGCCCAAGGTCTGCGGCCTGAGAGCCCCCCACCAGCCGGCCCCCTGCTCAACGGGGCCCCCGCTGGGGAGAGTCCCCAGCCTAAGGCCGCCCCCGAGGCCTCCTCGCCGCCTGCCTCACCCCTCCAGCATCTCCTGCCTGGAAAGGCTGTGGACCTTGGGCCCCCCAAGCCCAGCGACCAGGAGACTGGAGAGCAGGTGTCCAGCCCCAGCAGCCACCCCGCCCTCCACACCACCACCGAGGACAGTGCAGGGGTGCAGACTGAGTTCTAG
ORF Protein Sequence MGDVLSTHLDDARRQHIAEKTGKILTEFLQFYEDQYGVALFNSMRHEIEGTGLPQAQLLWRKVPLDERIVFSGNLFQHQEDSKKWRNRFSLVPHNYGLVLYENKAAYERQVPPRAVINSAGYKILTSVDQYLELIGNSLPGTTAKSGSAPILKCPTQFPLILWHPYARHYYFCMMTEAEQDKWQAVLQDCIRHCNNGIPEDSKVEGPAFTDAIRMYRQSKELYGTWEMLCGNEVQILSNLVMEELGPELKAELGPRLKGKPQERQRQWIQISDAVYHMVYEQAKARFEEVLSKVQQVQPAMQAVIRTDMDQIITSKEHLASKIRAFILPKAEVCVRNHVQPYIPSILEALMVPTSQGFTEVRDVFFKEVTDMNLNVINEGGIDKLGEYMEKLSRLAYHPLKMQSCYEKMESLRLDGLQQRFDVSSTSVFKQRAQIHMREQMDNAVYTFETLLHQELGKGPTKEELCKSIQRVLERVLKKYDYDSSSVRKRFFREALLQISIPFLLKKLAPTCKSELPRFQELIFEDFARFILVENTYEEVVLQTVMKDILQAVKEAAVQRKHNLYRDSMVMHNSDPNLHLLAEGAPIDWGEEYSNSGGGGSPSPSTPESATLSEKRRRAKQVVSVVQDEEVGLPFEASPESPPPASPDGVTEIRGLLAQGLRPESPPPAGPLLNGAPAGESPQPKAAPEASSPPASPLQHLLPGKAVDLGPPKPSDQETGEQVSSPSSHPALHTTTEDSAGVQTEF

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP2119-Ab Anti-NIBA2/ FAM129B/ C9orf88 monoclonal antibody
    Target Antigen GM-Tg-g-MP2119-Ag FAM129B VLP (virus-like particle)
    ORF Viral Vector pGMLV001974 Human NIBAN2 Lentivirus plasmid
    ORF Viral Vector vGMLV001974 Human NIBAN2 Lentivirus particle


    Target information

    Target ID GM-MP2119
    Target Name FAM129B
    Gene ID 64855, 227737, 707403, 362115, 101096769, 609251, 613747, 100070508
    Gene Symbol and Synonyms 9130404D14Rik,bA356B19.6,C9orf88,FAM129B,MEG-3,MINERVA,NIBAN2,OC58,RGD1307018
    Uniprot Accession Q96TA1
    Uniprot Entry Name NIBA2_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000136830
    Target Classification Not Available

    Enables transcription coactivator activity. Involved in several processes, including gonadotropin secretion; positive regulation of transcription regulatory region DNA binding activity; and regulation of cellular macromolecule biosynthetic process. Located in several cellular components, including adherens junction; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.